Moreover, IFN-γ and IL-2 secretion were found to be enriched in the tumor TME.<h4>Conclusion</h4>Our study indicated that combination of PO and anti-PD-1 could synergistically suppress CRC progression and altered the tumor microenvironment in favor of antitumor immune responses. The gene discussed is IFNG; the disease is colorectal carcinoma.